Brind.
  1. UChicago Medicine, NewcelX Ltd., and Eledon Pharmaceuticals provided data supporting current type 1 diabetes research and are seeking FIH trial approval for stem cell therapy under FDA clearance.

Nature Cell acquired a stem cell manufacturing facility and is seeking BLA filing for its stem cell therapy.

1 report, 1 independent Updated May 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Nature Cell acquired a stem cell manufacturing facility and is seeking BLA filing for its stem cell therapy.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped